Summary
Prognostic factors define the study population, help formulate the study objectives, and influence the treatment strategies. They must be accounted for in the study analysis to obtain valid estimates of the treatment differences and to evaluate results across studies. The causal relationship between a prognostic factor and the study endpoint can only be established through prospective randomized study designs. Potential factors discovered through retrospective analysis must be verified to establish their validity. Using such factors prematurely to select patient population and treatment strategy for a new study will not establish the validity of the potentially important factor.
Similar content being viewed by others
References
Badwe RR, Gregory WM, Chaudary MA, Richards MA, Bentley AE, Rubens RD: Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet 337:1261–1264, 1991.
Pocock SJ, Simon R: Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31:103–115, 1989.
Canner PL: Covariate adjustment of treatment effects in clinical trials. Controlled Clinical Trials 12:359–366, 1991.
Anderson GL: Mismodelling covariates in Cox regression. Unpublished Ph.D. thesis, University of Washington, 1989.
Beach ML, Meier P: Choosing covariates in the analysis of clinical trials. Controlled Clinical Trials 10:1615–1755, 1989.
Efron B, Gong G: A leisurely look at the bootstrap, the jackknife, and cross-validation. The American Statistician 37:36–48, 1983.
Author information
Authors and Affiliations
Additional information
Supported by NCI 5 PO1 CA53996-15 and NCI 5 U10 CA38926-08.
Rights and permissions
About this article
Cite this article
Dahlberg, S., Liu, PY. Prognostic factors in clinical trials. Breast Cancer Res Tr 22, 193–196 (1992). https://doi.org/10.1007/BF01840832
Issue Date:
DOI: https://doi.org/10.1007/BF01840832